Prostate Cancer
Clinical Review
Prostate-Specific Antigen Decline >50% After 4 Weeks of Treatment Is an Indicator of Better Progression Free and Overall Survival Both With Abiraterone and Enzalutamide in Metastatic Castrate Resistant Prostate Cancer
Clinical Review
Prostate Cancer in a Transgender Woman
Clinical Review
Evidence-Based Project and Quality Initiative Towards Improving Decision Making and Outcomes in Prostate Cancer Bone Health at Salt Lake City VA
Clinical Review
A Cognitive-Behavioral Stress Management Group for Men with Urologic Cancers: Pre- and Post-COVID
Conference Coverage
Better continence rate gives robotic prostatectomy the edge
A large trial confirms early continence is better with a robotic rather than classical laparoscopic approach.
Case Reports
Hypercalcemia Is of Uncertain Significance in Patients With Advanced Adenocarcinoma of the Prostate
Hypercalcemia in the setting of prostate cancer is rare with an uncertain pathophysiology and more research is needed into the role of parathyroid...
News
FDA approves olaparib for certain metastatic prostate cancers
News
First PARP inhibitor approved for metastatic prostate cancer
News
Combined biopsy method improves diagnostic accuracy in prostate cancer
Combining MRI-targeted and systematic biopsy resulted in 9.9% more prostate cancer diagnoses.
Article
Equal Access Makes A Difference in Surviving Prostate Cancer
Researchers examined whether African American men with prostate cancer who were treated in the VA had similar outcomes to white patients with...